More Articles

Medical

Taking clinical trials to the patient 

Andrew Stone, (Jan 22, 2022)

Putting patients at the center of trials in Japan using new tools and approaches
Access and Evidence

The future is bright for RWE in pharma approvals

Brian Eastwood, (Jan 6, 2022)

The FDA and other regulatory bodies are increasingly willing to accept real-world evidence as part of approvals. Pharma is up to the task
Medical

The shift towards digital technology for clinical research

Mary Nishikawa, (Dec 21, 2021)

Remote patient participation and trial monitoring can avoid the high risk of hospital visits 
Medical

Pharma’s new leaders in field engagement: MSLs

Andrew Stone, (Nov 30, 2021)

With the whole of pharma in various states of ‘hybridisation’, how can MSLs be supported to deliver enhanced personal service across physical and virtual engagements? 
Multichannel

Making medicines sustainable

Andrew Stone, (Nov 30, 2021)

There’s a new cross-healthcare initiative to cut medicines waste and lower carbon emissions while also improving healthcare equity and serving patients.  Pharma will be a key player
Patients and Medical

Reaching Gen-Z 

Risa Kerslake, (Nov 24, 2021)

Young people comprise a unique demographic that pharma is not used to serving but new digital tools offer ways to understand, engage and serve them better
Patients and Medical

Helping patients help themselves

Andrew Stone, (Nov 19, 2021)

Self care offers a new way for health care companies to serve patients better globally and industry collaboration will drive faster progress
Patients and Medical

Chiesi: Putting purpose at its heart

Andrew Stone, (Nov 10, 2021)

Italian pharma company Chiesi has embedded environmental and social purpose into its very corporate fabric
Multichannel

The evolution of the pharma incubator

Andrew Stone, (Nov 2, 2021)

Smarter use of venture capital, leveraging physical co-location, collaborating with the big tech accelerators and broad industry innovation consortia should help pharma incubators address the rapidly growing digital health sector
Multichannel

Speeding pharma’s slow sustainability journey

Andrew Stone, (Nov 2, 2021)

There’s much more pharma could and should do to drive positive change in the climate fight and action is no longer optional 

Pages